U.S. Stocks Edge Down as Investors Sell Tech Shares

Plus: AstraZeneca's Covid-19 vaccine faces fresh ban in Germany for people under 60. Federal Trade Commission challenges Illumina's planned acquisition of Grail. Charlie Turner reports. Learn more about your ad choices. Visit megaphone.fm/adchoices